Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.
Daniel E. Hilleman, PharmD, FCCP
Advertisement
Articles by Daniel E. Hilleman, PharmD, FCCP
This review summarizes the safety and efficacy of 3 new orally active anticoagulant drugs (dabigatran, rivaroxaban, apixaban) that can be used as alternatives to warfarin.
Advertisement
Latest Updated Articles
Hypertension: A Silent Killer Requiring Novel TherapiesJuly 19th 2025
- New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
December 11th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
Bridging the Gap: Pharmacist Experiences Obtaining DEA Licenses
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Comparison of Weight-Based vs Non–Weight-Based Norepinephrine Dosing in Patients With Septic Shock
5